Lymphoma & Leukaemia Research Review, Issue 53

In this issue:

Loncastuximab tesirine in R/R DLBCL
Glofitamab induces durable CRs in R/R B-cell lymphoma
Azacitidine vs semi-intensive fludarabine + cytarabine in AML
Inotuzumab and mini–hyper-CVD in R/R Ph– ALL
Ofatumumab + bendamustine in relapsed iNHL
Ibrutinib in classic and variant HCL
Autoimmune cytopaenias in CLL treated with targeted drugs
CAR-T cell therapy of B-ALL post allotransplant
Treatment-free remission in CML after second-line nilotinib
Pre-treatment with ibrutinib in CLL

Please login below to download this issue (PDF)

Subscribe